HomeIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Nakaraang pagsara
$0.00
Average na Volume
372.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | 2014info | Y/Y na pagbabago |
|---|---|---|
Kita | 28.89M | — |
Gastos sa pagpapatakbo | 33.07M | — |
Net na kita | -30.39M | — |
Net profit margin | -105.18 | — |
Kita sa bawat share | -0.58 | 30.12% |
EBITDA | -20.30M | — |
Aktuwal na % ng binabayarang buwis | -0.80% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | 2014info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 5.00M | — |
Kabuuang asset | 65.48M | — |
Kabuuang sagutin | 53.69M | — |
Kabuuang equity | 11.79M | — |
Natitirang share | 62.59M | — |
Presyo para makapag-book | 0.00 | — |
Return on assets | -19.15% | — |
Return on capital | -31.61% | — |
Cash Flow
Net change in cash
| (USD) | 2014info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -30.39M | — |
Cash mula sa mga operasyon | -10.91M | — |
Cash mula sa pag-invest | 4.49M | — |
Cash mula sa financing | 3.50M | — |
Net change in cash | -1.38M | — |
Malayang cash flow | 4.58M | — |
Tungkol
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Itinatag
2005
Headquarters
Website
Mga Empleyado
121
